Synthetic Biology’s Potential for Commercial Innovation Should Be Supported, Biotechnology Industry Organization (BIO) Argues

WASHINGTON--(BUSINESS WIRE)--Research and development in synthetic biology is an evolution of biotechnology innovation that should be supported and encouraged by federal regulatory policies. The Biotechnology Industry Organization (BIO) today announced publication of the Policy Forum article “Synthetic Biology: Regulating Industry Uses of New Biotechnologies” in this week’s edition of Science magazine.
MORE ON THIS TOPIC